Clinical Trial Update: A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib)

View source ↗

Summary

A completed clinical trial update examining long-term responses in non-small cell lung cancer patients treated with Tarceva (erlotinib), with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Status: COMPLETED | Results posted: 2017-10-24